Role of secondary cytoreductive surgery in ovarian cancer relapse: Who will benefit? A systematic analysis of 240 consecutive patients

Journal of Surgical Oncology

Volumn 102, Issue 6, 2010, Pages 656-662

  Sehouli, Jalid ^a   Richter, R ^a   Braicu, Elena Ioana ^a   Bühling, Kai J ^b   Bahra, Marcus ^a   Neuhaus, Peter ^a   Lichtenegger, Werner ^a   Fotopoulou, Christina ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

ovarian cancer relapse; platinum resistance; secondary tumor debulking; survival

Indexed keywords

PLATINUM;

ADULT; AGED; ARTICLE; ASCITES; CANCER MORTALITY; CANCER RELAPSE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DOCUMENTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVARY CANCER; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; VALIDITY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; PLATINUM COMPOUNDS; PROGNOSIS; TREATMENT OUTCOME;

EID: 78349260017     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21652     Document Type: Article

References (23)

1. Schorge JO, Wingo SN, Bhore R, et al.: Secondary cytoreductive surgery for recurrent platinum-sensitive ovarian cancer. Int J Gynaecol Obstet 2010; 108: 123-127.
2. Zang RY, Zhang ZY, Li ZT, et al.: Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer. J Surg Oncol 2000; 75: 24-30.
3. Zang RY, Li ZT, Tang J, et al.: Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: Who benefits? Cancer 2004; 100: 1152-1161. (Pubitemid 38325942)
4. Chi DS, McCaughty K, Diaz JP, et al.: Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer 2006; 106: 1933-1939.
5. Bae J, Lim MC, Choi JH, et al.: Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. J Gynecol Oncol 2009; 20: 101-106 [Epub June 29, 2009].
6. Harter P, du Bois A, Hahmann M, et al.: Surgery in recurrent ovarian cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Ann Surg Oncol 2006; 13: 1702-1710.
7. Harter P, Hahmann M, Lueck HJ, et al.: Surgery for recurrent ovarian cancer: Role of peritoneal carcinomatosis: Exploratory analysis of the DESKTOP I trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Ann Surg Oncol 2009; 16: 1324-1330 [Epub February 19, 2009].
8. International Federation of Gynecology and Obstetrics: Changing in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 1987; 156: 263-264.
9. Sehouli J, Senyuva F, Fotopoulou C, et al.: Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer. J Surg Oncol 2009; 99: 424-427.
10. Sehouli J, Kónsgen D, Mustea A, et al.: " IMO"-Intraoperative mapping of ovarian cancer. Zentralbl Gynakol 2003; 125: 129-135 [German].
11. Bristow RE,: Advanced cytoreductive surgery in gynecologic oncology. Gynecol Oncol 2009; 114: S1-S2.
12. Harter P, Hilpert F, Mahner S, et al.: Role of cytoreductive surgery in recurrent ovarian cancer. Expert Rev Anticancer Ther 2009; 9: 917-922 [review].
13. Eisenkop SM, Friedman RL, Wang HJ,: Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study. Cancer 1995; 76: 1606-1614.
14. Salani R, Santillan A, Zahurak ML, et al.: Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: Analysis of prognostic factors and survival outcome. Cancer 2007; 109: 685-691. (Pubitemid 46233229)
15. Onda T, Yoshikawa H, Yasugi T, et al.: Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: Proposal for patients selection. Br J Cancer 2005; 92: 1026-1032.
16. Pfisterer J, Harter P, Canzler U, et al.: The role of surgery in recurrent ovarian cancer. Int J Gynecol Cancer 2005; 15: 195-198.
17. Harter P, Sehouli J, Reuss A, et al.: Predictive factors for resection in recurrent ovarian cancer (ROC). Intergroup study of AGO KOMMISSION OVAR, AGO-OVAR, AGO AUSTRIA, MITO AND NOGGO. 12th Biennial Meeting International Gynecologic Cancer Society; October 25-28, 2008; Bangkok, 2008 [abstract 38].
18. Gadducci A, Iacconi P, Cosio S, et al.: Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gynecol Oncol 2000; 79: 344-349.
19. Jänicke F, Hólscher M, Kuhn W, et al.: Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer 1992; 70: 2129-2136.
20. Bristow RE, Puri I, Chi DS,: Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis. Gynecol Oncol 2009; 112: 265-274 [Epub October 19, 2008, review].
21. Benedetti Panici P, De Vivo A, Bellati F, et al.: Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer. Ann Surg Oncol 2007; 14: 1136-1142 [Epub December 31, 2006].
22. Alejandro Rauh-Hain J, Olawaiye AB, Munro EG, et al.: Role of computed tomography in the surgical management of patients with bowel obstruction secondary to recurrent ovarian carcinoma. Ann Surg Oncol 2009 Nov 18. [Epub ahead of print].
23. Tebes SJ, Sayer RA, Palmer JM, et al.: Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol 2007; 106: 482-487 [Epub June 27, 2007].